title: Reduced apoptosis and increased inflammatory cytokines in granulomas caused by tuberculous compared to non-tuberculous mycobacteria: role of MPT64 antigen in apoptosis and immune response.
abstract: Inhibition of apoptosis of infected macrophages by pathogenic mycobacteria is suggested to be an important virulence mechanism, but little is known about the mycobacterial proteins involved in the inhibition of apoptosis. In this study we investigated differences in apoptosis and immune response and their correlation with the expression of Mycobacterium tuberculosis complex-specific secretory protein MPT64 in lesions caused by tuberculous or non-tuberculous mycobacteria by analysing the in situ expression of apoptosis-related proteins (FasL, Fas, Bax, Bcl-2), apoptotic cells, inflammatory cytokines [tumour necrosis factor (TNF)-alpha, interleukin (IL)-10, transforming growth factor (TGF)-beta, interferon (IFN)-gamma] and MPT64 antigen. The discrimination of mycobacteria was made by nested polymerase chain reaction (PCR) amplification of IS6110, which is specific for M. tuberculosis complex organisms. Forty-seven cases of lymphadenitis with necrotic granulomas were evaluated. With nested PCR, 30/47 cases were positive for M. tuberculosis. MPT64 antigen was detected specifically in the PCR-positive cases. Granulomas caused by tuberculous mycobacteria had fewer apoptotic cells, higher numbers of cells expressing TNF-alpha and TGF-beta and less extensive necrosis than granulomas caused by non-tuberculous mycobacteria. There was a significant negative correlation between apoptotic cells and the number of cells expressing MPT64 antigens, suggesting a role for MPT64 protein in the inhibition of apoptosis. Granulomas with higher amounts of MPT64 also showed a greater number of cells expressing TGF-beta than those with lower amounts of MPT64. In conclusion, this study supports the hypothesis that inhibition of apoptosis is a virulence mechanism for tuberculous mycobacteria. Correlation of MPT64 antigen with expression of macrophage deactivating cytokines and reduced apoptosis suggests its role in pathogenesis and bacillary persistence.
authors: Section for Microbiology and Immunology, The Gade Institute, University of Bergen, Bergen, Norway. tehmina.mustafa@cih.uib.no
authors: T
authors: T
authors: Mustafa
authors: H G
authors: HG
authors: Wiker
authors: O
authors: O
authors: Mørkve
authors: L
authors: L
authors: Sviland
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000942:Antigens, Bacterial / Q000276:immunology / Q000378:metabolism; D017209:Apoptosis; D001426:Bacterial Proteins / Q000276:immunology* / Q000378:metabolism; D002648:Child; D002675:Child, Preschool; D016207:Cytokines / Q000378:metabolism*; D053222:Fas Ligand Protein / Q000378:metabolism; D005260:Female; D006099:Granuloma / Q000276:immunology* / Q000382:microbiology / Q000473:pathology; D006801:Humans; D018836:Inflammation Mediators / Q000378:metabolism; D008198:Lymph Nodes / Q000276:immunology / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009161:Mycobacterium / Q000276:immunology; D009164:Mycobacterium Infections / Q000276:immunology / Q000473:pathology; D009169:Mycobacterium tuberculosis / Q000276:immunology / Q000472:pathogenicity; D016133:Polymerase Chain Reaction / Q000379:methods; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000378:metabolism; D014388:Tuberculosis, Lymph Node / Q000276:immunology* / Q000382:microbiology / Q000473:pathology; D014774:Virulence; D051028:bcl-2-Associated X Protein / Q000378:metabolism; D019014:fas Receptor / Q000378:metabolism
chemical_list: D000942:Antigens, Bacterial; C494826:BAX protein, human; D001426:Bacterial Proteins; D016207:Cytokines; C505661:FASLG protein, human; D053222:Fas Ligand Protein; D018836:Inflammation Mediators; D019253:Proto-Oncogene Proteins c-bcl-2; D051028:bcl-2-Associated X Protein; D019014:fas Receptor; C060216:MPB70 protein, Mycobacterium bovis
references: Arch Med Res. 2003 Jan-Feb;34(1):20-5
references: 12604370
references: Clin Exp Immunol. 1999 Apr;116(1):94-9
references: 10209511
references: Br J Cancer. 1972 Aug;26(4):239-57
references: 4561027
references: Infect Immun. 1986 Apr;52(1):293-302
references: 3514457
references: Cell. 1989 Mar 10;56(5):731-40
references: 2647299
references: J Immunol. 1989 Jun 15;142(12):4295-300
references: 2542408
references: Science. 1999 May 28;284(5419):1520-3
references: 10348738
references: East Afr Med J. 2004 Apr;81(4):171-8
references: 15884281
references: Immunol Cell Biol. 2005 Dec;83(6):643-50
references: 16266317
references: Immunology. 2006 Apr;117(4):454-62
references: 16556259
references: Mod Pathol. 2006 Dec;19(12):1606-14
references: 16980944
references: Inflammation. 1999 Dec;23(6):507-21
references: 10565565
references: J Leukoc Biol. 1999 Nov;66(5):763-4
references: 10577507
references: J Immunol. 2000 Feb 15;164(4):2016-20
references: 10657653
references: J Pathol. 2000 Aug;191(4):417-25
references: 10918217
references: Scand J Infect Dis. 2001;33(6):405-7
references: 11450857
references: Scand J Immunol. 2001 Dec;54(6):630-9
references: 11902340
references: Scand J Immunol. 2002 Oct;56(4):383-91
references: 12234259
references: Infect Immun. 1990 Aug;58(8):2675-7
references: 2115027
references: Infect Immun. 1991 Aug;59(8):2567-72
references: 1906841
references: Immunol Today. 1991 Jul;12(7):228-33
references: 1822092
references: J Exp Med. 1993 Dec 1;178(6):2243-7
references: 8245795
references: J Exp Med. 1994 Oct 1;180(4):1499-509
references: 7931080
references: J Immunol. 1995 Jan 1;154(1):465-73
references: 7995958
references: Immunology. 1994 Aug;82(4):591-5
references: 7835922
references: Scand J Immunol. 1995 Jun;41(6):539-44
references: 7770723
references: Immunity. 1995 Jun;2(6):561-72
references: 7540941
references: J Exp Med. 1995 Dec 1;182(6):1777-83
references: 7500022
references: Am J Respir Cell Mol Biol. 1996 Jul;15(1):64-70
references: 8679223
references: Infect Immun. 1996 Dec;64(12):5384-9
references: 8945591
references: J Immunol. 1997 Jan 1;158(1):315-21
references: 8977205
references: Cell. 1997 Feb 7;88(3):355-65
references: 9039262
references: Scand J Immunol. 1997 Feb;45(2):115-31
references: 9042423
references: Immunology. 1997 Apr;90(4):607-17
references: 9176116
references: J Immunol. 1997 Aug 15;159(4):1594-8
references: 9257817
references: J Immunol. 1997 Sep 15;159(6):3034-43
references: 9300729
references: Eur J Immunol. 1997 Sep;27(9):2450-6
references: 9341792
references: Immunology. 1997 Sep;92(1):1-5
references: 9370916
references: J Lab Clin Med. 1997 Nov;130(5):469-75
references: 9390634
references: Infect Immun. 1998 Jul;66(7):3454-6
references: 9632623
references: Int J Tuberc Lung Dis. 1998 Jul;2(7):541-6
references: 9661819
references: J Immunol. 1998 Sep 1;161(5):2636-41
references: 9725266
references: J Infect Dis. 1998 Oct;178(4):1105-14
references: 9806041
references: J Immunol. 1999 Mar 1;162(5):3031-6
references: 10072555
references: Am J Respir Cell Mol Biol. 2003 Nov;29(5):545-51
references: 12748057